Document is current
Any future updates will be listed below
-
Authors
Sandoval-Montoya, G.
Romero-Sáez, M.
Buitrago-Sierra, R.
Uribe, D.
Ramírez-Sánchez, C. https://orcid.org/0000-0002-6538-0812
-
Funding
Funding for this research was provided by:
Instituto Tecnológico Metropolitano (P23205)
- License Information
-
More Information
Article History
Received: 8 May 2025
Revised: 22 January 2026
Accepted: 1 April 2026
First Online: 10 June 2026
Declarations
:
: The authors declare that they have no conflict of interest.
: This study is classified as low-risk research because its execution involves in vitro experiments with a well characterized human continuous cell line ( HepG2 , ATCC HB-8065), that do not contain biological agents that could represent a risk to human or animal health or to the environment. In addition, none of the project stages includes the use of confidential information or the performance of tests on humans or animals.
